Roche’s virtual event on key oncology data presented at ASCO 2021
Agenda:
Early pipeline programs in focus
Late-stage pipeline programs in focus
ASCO 2021 Highlight
Q&A
William Pao, M.D., Ph.D.,Global Head of Roche Pharma Research and Early Development
Ira Mellman, Ph.D., Vice President, Cancer Immunology, Genentech Research & Early Development
Levi Garraway, M.D., Ph.D., Chief Medical Officer and Head of Global Product Development
Tecentriq in adjuvant NSCLC: Phase 3 IMpower010 primary results
Heather Wakelee, M.D., Prof. of Medicine, Stanford University Medical Center / Deputy Director Stanford Cancer Institute